☆REGENERON PHARMACEUTICALS, INC. (REGN)
Quality Q
0.000
AUM ($M)
177
Positions
3
Turnover
0.65
Top-10 wt
100%
Herfindahl
0.539
History (qtrs)
6
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 4 positions · portfolio value $177M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆PBLS funds › | Parabilis Medicines, Inc. | NEW | Common Stock | 64.4% | +64.4% | 114.0 | 4,166,666 | +4,166,666 | 0 | — |
| ☆NTLA funds › | Intellia Therapeutics, Inc. | HOLD | Common Stock | 35.4% | -63.8% | 62.7 | 3,702,995 | +0 | 0 | — |
| ☆ACET funds › | Adicet Bio, Inc. | NEW | Common Stock | 0.3% | +0.3% | 0.5 | 60,511 | +60,511 | 0 | — |
| ☆CUSIP:007002108 funds › | Adicet Bio, Inc. | EXIT | — | 0.0% | -0.9% | 0.0 | 0 | -60,511 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 177 | 3 | 0.65 | 100% | 0.539 | 0.000 | — | out |
| 2026Q1 | 48 | 2 | 0.01 | 100% | 0.983 | 0.000 | — | out |
| 2025Q4 | 34 | 2 | 0.91 | 100% | 0.970 | 0.000 | — | left |
| 2025Q3 | 700 | 4 | 0.07 | 100% | 0.830 | 0.913 | — | in |
| 2025Q2 | 1,485 | 4 | 0.01 | 100% | 0.953 | 0.972 | — | entered |
| 2025Q1 | 1,234 | 6 | 0.00 | 100% | 0.946 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status